C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
530/13, 195/1.22
C12N 15/62 (2006.01) A61K 38/16 (2006.01) A61K 38/17 (2006.01) A61K 39/21 (2006.01) C07K 14/035 (2006.01) C07K 14/15 (2006.01) C07K 14/16 (2006.01) C07K 14/245 (2006.01) C07K 14/47 (2006.01) C07K 19/00 (2006.01) C12N 15/12 (2006.01) C12N 15/31 (2006.01) C12N 15/85 (2006.01) C12P 21/00 (2006.01) C12Q 1/48 (2006.01) A61K 39/00 (2006.01)
Patent
CA 1341476
Diagnostic product and vaccine for Acquired Immuno-deficiency Syndrome (AIDS) and methods for making and using same, wherein viral polypeptide sequences from an AIDS associated retrovirus are expressed directly or as a fusion polypeptide in a prokaryotic or mammalian cell expression host to produce a diagnostic product which specifically binds complementary antibody produced by individuals afflicted with AIDS or a vaccine against AIDS which confers resistance to infection by AIDS associated retrovirus. the reverse transcriptase of an AIDS associated retrovirus is used separately or in a whole cell assay to identify compounds which selectively inhibit retroviral reverse transcriptase.
498600
Capon Daniel Jeffrey
Lasky Laurence Allan
Battison Williams Dupuis
Genentech Inc.
LandOfFree
Moleculary cloned acquired immunodeficiency syndrome... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Moleculary cloned acquired immunodeficiency syndrome..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Moleculary cloned acquired immunodeficiency syndrome... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1200809